During their first year, fellows investigate opportunities for basic or translational research in hematology or cancer biology, or a clinical research program in the UH Seidman Cancer Center. In order to attain dual board certification from the ABIM, fellows are required to do 18 months of research and scholarly activity during their fellowship.

Program and division directors work with each first-year fellow to identify areas of interest, potential clinical and research mentors, and draft a research plan. We help fellows use these research plans as a basis for applications to the ASCO Vail Clinical Trials Workshop, ASH CRTI (Clinical Research Training Institute), AACR Methods in Molecular Biology, or ASBMT. More than half of our 2015 fellows have participated in VAIL or ASH CRTI during their first or second years of training.

Fellows are encouraged to present their research results at national meetings (ASCO, ASH, ASBMT).

A wide variety of ongoing research (within the Division of Hematology and Oncology and in other divisions and centers within the School of Medicine) is available to hematology-oncology fellows.

Areas of research expertise include:

Multidisciplinary Subspecialty Programs:

Quality and outcomes research as well as palliative care are represented within the program, and have served as excellent bases for fellow research in the past. For more detailed information regarding research foci of the faculty, please click here.

Additional Research Training Opportunities:
A K12 Training Grant for development of translation investigators in the advanced fellow stage or junior faculty positions is available [Stanton Gerson, MD, (PI) and Neal Meropol, MD (Co-PI)].